Latest News on CLOV

Financial News Based On Company


Advertisement
Advertisement

Is the Market Bullish or Bearish on Clover Health Investments? - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/insights/short-sellers/25/08/47131559/is-the-market-bullish-or-bearish-on-clover-health-investments
Clover Health Investments's CLOV short percent of float has risen 12.43% since its last report. The company recently reported that it has 41.04 million shares sold short, which is 10.04% of all regular shares that are available for trading.

CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View

https://www.zacks.com/stock/news/2673484/clov-q2-earnings-in-line-stock-falls-on-raised-insurance-ber-view
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.

Clover Health ( CLOV ) Q2 Sales Up 34%

https://www.fool.com/data-news/2025/08/06/clover-health-clov-q2-sales-up-34/
Clover Health Investments ( NASDAQ:CLOV ) , a technology-focused Medicare Advantage insurer, reported its Q2 2025 results on August 5, 2025. The most notable news was robust revenue growth, with GAAP sales climbing to $477.6 million-surpassing analyst expectations of $468.3 million ( GAAP ) .

Clover Health Investments, Corp. ( CLOV ) Q2 Earnings Meet Estimates

https://www.zacks.com/stock/news/2669774/clover-health-investments-corp-clov-q2-earnings-meet-estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 0.00% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease

https://www.globenewswire.com/news-release/2025/08/04/3126919/0/en/Primary-Care-Physician-Use-of-Counterpart-Assistant-Technology-Linked-to-Better-Health-Outcomes-in-Patients-with-Chronic-Obstructive-Pulmonary-Disease.html
New whitepaper shows that a relationship with a primary care physician ( "PCP" ) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease ( "COPD" ) diagnosis, increased specialty care, and meaningful reductions in hospitalizations ( 15% lower ) and ...
Advertisement

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/08/g46840418/primary-care-physician-use-of-counterpart-assistant-technology-linked-to-better-health-outcomes-in
New whitepaper shows that a relationship with a primary care physician ( "PCP" ) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease ( "COPD" ) diagnosis, increased specialty care, and meaningful reductions in hospitalizations ( 15% lower ) and ...

Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?

https://www.zacks.com/stock/news/2648644/clover-health-pre-q2-earnings-analysis-buy-sell-or-hold-the-stock
CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution

https://www.globenewswire.com/news-release/2025/07/29/3123647/0/en/Counterpart-Health-Appoints-Vicky-Bruner-as-Vice-President-of-Operations-to-Support-Expansion-and-Customer-Execution.html
WILMINGTON, Del., July 29, 2025 ( GLOBE NEWSWIRE ) -- Counterpart Health, Inc. ( "Counterpart" ) , a wholly owned subsidiary of Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) and a leading AI-powered physician-enablement platform, today announced ...

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/07/g46705959/counterpart-health-appoints-vicky-bruner-as-vice-president-of-operations-to-support-expansion-and-
WILMINGTON, Del., July 29, 2025 ( GLOBE NEWSWIRE ) -- Counterpart Health, Inc. ( "Counterpart" ) , a wholly owned subsidiary of Clover Health Investments, Corp.

Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech ( NASDAQ:AIRE ) , Agilysys ( NASDAQ:AGYS )

https://www.benzinga.com/trading-ideas/movers/25/07/46538482/why-medpace-shares-are-trading-higher-by-45-here-are-20-stocks-moving-premarket
Shares of Medpace Holdings, Inc. MEDP rose sharply in pre-market trading after the company reported strong financial results for the second quarter and raised its full-year guidance. Medpace expects 2025 revenue to be in the range of $2.42 billion to $2.52 billion, up from prior guidance of $2.14 ...
Advertisement

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference

https://www.globenewswire.com/news-release/2025/07/21/3119021/0/en/Clover-Health-to-Participate-in-Upcoming-Canaccord-Genuity-45th-Annual-Growth-Conference.html
WILMINGTON, Del., July 21, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on ...

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/07/g46531804/clover-health-to-participate-in-upcoming-canaccord-genuity-45th-annual-growth-conference
WILMINGTON, Del., July 21, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, ...

What's Going On With Clover Health Stock? - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/trading-ideas/movers/25/07/46299575/whats-going-on-with-clover-health-stock
Clover shares are rising Tuesday, adding to strong gains over the past week. The company schedules its second-quarter earnings for after the market close on Aug. 5. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Clover Health Investments, Corp.

Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025

https://www.globenewswire.com/news-release/2025/07/08/3111738/0/en/Clover-Health-to-Report-Second-Quarter-2025-Financial-Results-on-August-5-2025.html
WILMINGTON, Del., July 08, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) , today announced that it will release its financial results after the market closes on Tuesday, August 5, 2025.

Centene Pulls 2025 Guidance as Marketplace Growth Falters

https://www.zacks.com/stock/news/2560842/centene-pulls-2025-guidance-as-marketplace-growth-falters
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
Advertisement

Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment

https://www.zacks.com/stock/news/2558270/cigna-expands-coverage-with-rhinaer-enhances-rhinitis-treatment
CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.

Clover Health Set to Join Russell 3000® Index - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/06/g46166504/clover-health-set-to-join-russell-3000-index
WILMINGTON, Del., June 30, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover Health" ) , announced that it is set to join the broad-market Russell 3000® Index, effective after the US market opens today, June 30, 2025, as part of the 2025 Russell indexes reconstitution.

Here's Why MOH Shares Are Attracting Prudent Investors Now

https://www.zacks.com/stock/news/2520849/heres-why-moh-shares-are-attracting-prudent-investors-now
Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.

Chamath Palihapitiya Asks If He Should Launch Another SPAC-70% Say No, Users Warn of Past Failures: 'No Crying In The Casino!' - Clover Health Investments ( NASDAQ:CLOV ) , Opendoor Technologies ( NASDAQ:OPEN )

https://www.benzinga.com/markets/equities/25/06/46012786/chamath-palihapitiya-asks-if-he-should-launch-another-spac-70-say-no-users-warn-of-past-failures
Venture capitalist Chamath Palihapitiya sparked debate on social media by polling followers about launching another Special Purpose Acquisition Company ( SPAC ) , with 70.7% of 55,458 respondents voting "no" amid warnings about his troubled SPAC track record.

Ensign Enhances Presence With 3 New Acquisitions in 2 States

https://www.zacks.com/stock/news/2483617/ensign-enhances-presence-with-3-new-acquisitions-in-2-states
ENSG adds three skilled nursing facilities in Idaho and California, boosting its U.S. footprint and fueling future growth.
Advertisement

Here's Why You Should Hold Cigna Stock in Your Portfolio for Now

https://www.zacks.com/stock/news/2480533/heres-why-you-should-hold-cigna-stock-in-your-portfolio-for-now
CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

Here's Why You Should Add Pediatrix Medical to Your Portfolio Now

https://www.zacks.com/stock/news/2478230/heres-why-you-should-add-pediatrix-medical-to-your-portfolio-now
MD rises 5.6% YTD as earnings beat, hospital deals and lower costs drive growth. The Zacks Rank #2 signals strong near-term prospects.

Here's Why Encompass Health Shares Are Attracting Investors Now

https://www.zacks.com/stock/news/2477770/heres-why-encompass-health-shares-are-attracting-investors-now
EHC stock jumps 28.8% YTD as investors rally behind strong earnings beat, raised 2025 guidance and a growing national rehab hospital footprint.

Are Medical Stocks Lagging Atossa Genetics ( ATOS ) This Year?

https://www.zacks.com/stock/news/2471781/are-medical-stocks-lagging-atossa-genetics-atos-this-year
Here is how Atossa Genetics Inc. (ATOS) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

All You Need to Know About Clover Health Investments ( CLOV ) Rating Upgrade to Strong Buy

https://www.zacks.com/stock/news/2467014/all-you-need-to-know-about-clover-health-investments-clov-rating-upgrade-to-strong-buy
Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Advertisement

Clover Health ( CLOV ) Stock Soars This Week On Q1 Profitability, Up 320% Over Past Year - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/news/25/05/45324397/clover-health-clov-stock-soars-this-week-on-q1-profitability-up-320-over-past-year
Shares of Clover Health have surged 8.7% this week. The company reported Q1 results that highlighted rising profitability. Don't miss this list of 10 overlooked stocks-including one paying a 9% dividend-before Wall Street catches on.

Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2 - Ardent Health Partners ( NYSE:ARDT ) , Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/25/05/45282981/top-3-health-care-stocks-that-could-sink-your-portfolio-in-q2
As of May 8, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices ...

CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y

https://www.zacks.com/stock/news/2464332/clov-stock-rises-as-q1-earnings-beat-estimates-revenues-up-yy
Clover Health's first-quarter 2025 results continue to benefit from the strength of its strong member retention. A decline in operating loss bodes well.

Clover Health Investments, Corp. ( CLOV ) Surpasses Q1 Earnings Estimates

https://www.zacks.com/stock/news/2463480/clover-health-investments-corp-clov-surpasses-q1-earnings-estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 171.43% and 3.06%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

https://www.zacks.com/stock/news/2462220/watch-these-3-medtech-stocks-for-q1-earnings-beat-or-miss
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
Advertisement

Clover Health Announces Changes to Board of Directors

https://www.globenewswire.com/news-release/2025/04/22/3065951/0/en/Clover-Health-Announces-Changes-to-Board-of-Directors.html
Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders' Meeting Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate ...

Clover Health Announces Changes to Board of Directors - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/04/g44938080/clover-health-announces-changes-to-board-of-directors
WILMINGTON, Del., April 22, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover," "Clover Health" or the "Company" ) , today announced that after four years of distinguished service, Lee A.

Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025 - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/04/g44700226/clover-health-to-report-first-quarter-2025-financial-results-on-may-6-2025
WILMINGTON, Del., April 08, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover," "Clover Health" or the "Company" ) , today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6, 2025.

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/04/g44673676/clover-health-appoints-industry-veteran-as-chief-medical-officer-of-medicare-advantage
WILMINGTON, Del., April 07, 2025 ( GLOBE NEWSWIRE ) -- Clover Health Investments, Corp. CLOV ( "Clover," "Clover Health" or the "Company" ) , today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer ( "CMO" ) .

Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday? - SPDR S&P 500 ( ARCA:SPY )

https://www.benzinga.com/general/market-summary/25/02/44051518/nvidia-tesla-lead-tech-stock-rebound-whats-driving-markets-friday
Nvidia and Tesla rebound on Friday, leading tech stocks higher. PCE data provides some relief to investors as the price index marked its first decline in four months. Our government trade tracker caught Pelosi's 169% AI winner. Discover how to track all 535 Congress member stock trades today.
Advertisement

CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises

https://www.zacks.com/stock/news/2423574/clov-q4-earnings-beat-estimates-sales-miss-membership-rises
Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.

Clover Health Investments, Corp. ( CLOV ) Tops Q4 Earnings Estimates

https://www.zacks.com/stock/news/2423310/clover-health-investments-corp-clov-tops-q4-earnings-estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 128.57% and 2.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday? - SPDR S&P 500 ( ARCA:SPY )

https://www.benzinga.com/general/market-summary/25/02/44018084/trumps-tariffs-potential-stagflation-whats-driving-markets-thursday
Wall Street digests a slew of new economic data including soaring jobless claims and pending home sales dropping to the lowest level ever. President Donald Trump confirms 25% tariffs on Mexico and Canada will go into effect on March 4.

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. - Advanced Micro Devices ( NASDAQ:AMD ) , ASML Holding ( NASDAQ:ASML )

https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company
Clover Health Investments is losing a lot of money, says Cramer. Cramer says ASML Holding is a "remarkably great" company. Get the Real Story Behind Every Major Earnings Report On CNBC's "Mad Money Lightning Round," Jim Cramer said Rigetti Computing, Inc.

Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/25/01/g42945023/clover-health-reports-27-growth-in-medicare-advantage-membership-surpassing-100-000-lives-after-st
Robust plan benefits powered member growth, mainly driven by switchers from other plans Company will focus on balancing profitability with strategic investments in growth and technology to take advantage of strong market opportunity ~95% of Clover's January 1, 2025 membership is in its flagship ...
Advertisement

Is Medpace ( MEDP ) Stock Outpacing Its Medical Peers This Year?

https://www.zacks.com/stock/news/2387502/is-medpace-medp-stock-outpacing-its-medical-peers-this-year
Here is how Medpace (MEDP) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run

https://www.zacks.com/stock/news/2386986/4-medtech-stocks-that-gained-more-than-100-in-2024-with-room-to-run
Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.

Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

https://www.globenewswire.com/news-release/2024/12/17/2998614/0/en/Clover-Health-to-Participate-in-Upcoming-43rd-Annual-J-P-Morgan-Healthcare-Conference.html
JERSEY CITY, N.J., Dec. 17, 2024 ( GLOBE NEWSWIRE ) -- Remote-First Company -- Clover Health Investments, Corp. ( Nasdaq: CLOV ) ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P.

Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/pressreleases/24/12/g42540019/clover-health-to-participate-in-upcoming-43rd-annual-j-p-morgan-healthcare-conference
JERSEY CITY, N.J., Dec. 17, 2024 ( GLOBE NEWSWIRE ) -- Remote-First Company -- Clover Health Investments, Corp. CLOV ( "Clover," "Clover Health" or the "Company" ) , today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P.

( CLOV ) - Analyzing Clover Health Investments's Short Interest - Clover Health Investments ( NASDAQ:CLOV )

https://www.benzinga.com/insights/short-sellers/24/12/42413200/clov-analyzing-clover-health-investmentss-short-interest
Clover Health Investments's CLOV short percent of float has fallen 11.18% since its last report. The company recently reported that it has 16.44 million shares sold short, which is 4.05% of all regular shares that are available for trading.
Advertisement

Here's Why Clover Health Investments ( CLOV ) Could be Great Choice for a Bottom Fisher

https://www.zacks.com/stock/news/2379567/heres-why-clover-health-investments-clov-could-be-great-choice-for-a-bottom-fisher
After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health

https://www.zacks.com/stock/news/2379249/the-zacks-analyst-blog-highlights-inspire-medical-omnicell-talkspace-butterfly-network-and-clover-health
Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health are included in this Analyst Blog.

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

https://www.zacks.com/stock/news/2378675/5-medical-info-system-stocks-to-buy-for-a-stable-portfolio-in-2025
Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

Has CareDx ( CDNA ) Outpaced Other Medical Stocks This Year?

https://www.zacks.com/stock/news/2378239/has-caredx-cdna-outpaced-other-medical-stocks-this-year
Here is how CareDx (CDNA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

Down -26.32% in 4 Weeks, Here's Why Clover Health Investments ( CLOV ) Looks Ripe for a Turnaround

https://www.zacks.com/stock/news/2370977/down--2632-in-4-weeks-heres-why-clover-health-investments-clov-looks-ripe-for-a-turnaround
Clover Health Investments (CLOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in ...
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion